Dian-lei Liu
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Oridonin enhances the anti-tumor activity of gemcitabine towards pancreatic cancer by stimulating Bax- and Smac-dependent apoptosis.
Journal: Translational cancer research
Published: December 28, 2019
Effects of emodin on the demethylation of tumor-suppressor genes in pancreatic cancer PANC-1 cells.
Journal: Oncology reports
Published: February 05, 2015
Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent signaling pathway.
Journal: Molecular medicine reports
Published: April 09, 2014
The distinct mechanisms of the antitumor activity of emodin in different types of cancer (Review).
Journal: Oncology reports
Published: June 21, 2013
Emodin sensitizes the gemcitabine-resistant cell line Bxpc-3/Gem to gemcitabine via downregulation of NF-κB and its regulated targets.
Journal: International journal of oncology
Published: December 16, 2012
Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis.
Journal: PloS one
Published: March 22, 2012
Emodin potentiates the antitumor effects of gemcitabine in PANC-1 pancreatic cancer xenograft model in vivo via inhibition of inhibitors of apoptosis.
Journal: International journal of oncology
Published: November 13, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026